BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $995 | -21.1% | 26,654 | -0.7% | 0.02% | -14.8% |
Q2 2023 | $1,261 | +8.0% | 26,836 | -6.8% | 0.03% | 0.0% |
Q1 2023 | $1,168 | -26.0% | 28,781 | -7.1% | 0.03% | -30.8% |
Q4 2022 | $1,579 | -99.9% | 30,988 | +3.6% | 0.04% | -13.3% |
Q3 2022 | $1,610,000 | -15.6% | 29,903 | +0.7% | 0.04% | -8.2% |
Q2 2022 | $1,908,000 | -16.5% | 29,696 | +0.7% | 0.05% | -3.9% |
Q1 2022 | $2,286,000 | -7.7% | 29,486 | +2.2% | 0.05% | -5.6% |
Q4 2021 | $2,477,000 | +5.4% | 28,857 | -1.3% | 0.05% | -1.8% |
Q3 2021 | $2,351,000 | -2.0% | 29,228 | -1.9% | 0.06% | -1.8% |
Q2 2021 | $2,400,000 | -5.0% | 29,808 | -0.4% | 0.06% | -11.1% |
Q1 2021 | $2,525,000 | +5.0% | 29,938 | -0.1% | 0.06% | +3.3% |
Q4 2020 | $2,404,000 | -0.1% | 29,955 | +0.1% | 0.06% | -9.0% |
Q3 2020 | $2,406,000 | -11.3% | 29,915 | -5.0% | 0.07% | -15.2% |
Q2 2020 | $2,711,000 | +3.4% | 31,485 | -2.5% | 0.08% | -16.0% |
Q1 2020 | $2,623,000 | -38.7% | 32,302 | -36.8% | 0.09% | -19.7% |
Q4 2019 | $4,276,000 | -26.6% | 51,133 | -23.3% | 0.12% | -31.2% |
Q3 2019 | $5,829,000 | +5.0% | 66,642 | -1.7% | 0.17% | +9.0% |
Q2 2019 | $5,552,000 | -5.4% | 67,788 | -6.1% | 0.16% | -6.6% |
Q1 2019 | $5,871,000 | +29.3% | 72,203 | +4.7% | 0.17% | +18.4% |
Q4 2018 | $4,539,000 | -28.3% | 68,965 | -16.0% | 0.14% | -12.4% |
Q3 2018 | $6,329,000 | -2.2% | 82,096 | -6.3% | 0.16% | -7.5% |
Q2 2018 | $6,470,000 | +40.6% | 87,617 | +23.8% | 0.17% | +46.2% |
Q1 2018 | $4,602,000 | -10.0% | 70,754 | -10.5% | 0.12% | -3.3% |
Q4 2017 | $5,111,000 | +52.1% | 79,076 | +47.7% | 0.12% | +41.4% |
Q3 2017 | $3,361,000 | 0.0% | 53,554 | 0.0% | 0.09% | 0.0% |
Q3 2016 | $3,361,000 | – | 53,554 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |